A novel pegylated bispecific antibody-drug conjugate (P-BsADC) targeting Her2+cancers with improved efficacy and therapeutic window

被引：0
|
作者：
Wen, Yu
Yin, Shuqiang
Lyu, Weidong
Lei, Yang
Zhuo, Qiudong
Wu, Zibin
Sun, Bin
Tan, Shuangyu
Jiang, Lidong
Zhang, Teng
Gao, Bo
Xu, Rui
Li, Yong
Zheng, Liling
Liu, Shumin
Wu, David
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4000
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ZW49, a HER2-targeted biparatopic antibody-drug conjugate for the treatment of HER2-expressing cancers
    Hamblett, Kevin J.
    Hammond, Phil W.
    Barnscher, Stuart D.
    Fung, Vincent K.
    Davies, Rupert H.
    Wickman, Grant R.
    Hernandez, Andrea
    Ding, Tong
    Galey, Adam S.
    Winters, Geoffrey C.
    Rich, Jamie R.
    Babcook, John S.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization
    Hashimoto, Yuuri
    Koyama, Kumiko
    Kamai, Yasuki
    Hirotani, Kenji
    Ogitani, Yusuke
    Zembutsu, Akiko
    Abe, Manabu
    Kaneda, Yuki
    Maeda, Naoyuki
    Shiose, Yoshinobu
    Iguchi, Takuma
    Ishizaka, Tomomichi
    Karibe, Tsuyoshi
    Hayakawa, Ichiro
    Morita, Koji
    Nakada, Takashi
    Nomura, Taisei
    Wakita, Kenichi
    Kagari, Takashi
    Abe, Yuki
    Murakami, Masato
    Ueno, Suguru
    Agatsuma, Toshinori
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7151 - 7161
  • [33] Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers
    Min, Yijia
    Chen, Yu
    Wang, Lei
    Ke, Yong
    Rong, Fan
    He, Qunye
    Paerhati, Pameila
    Zong, Huifang
    Zhu, Jianwei
    Wang, Yin
    Zhang, Baohong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [34] AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors
    Weng, Weining
    Meng, Tao
    Pu, Junyi
    Ma, Linjie
    Shen, Yi
    Wang, Zhaohui
    Pan, Rong
    Wang, Mingqiao
    Chen, Caiwei
    Wang, Lijun
    Zhang, Jianjian
    Zhou, Biao
    Shao, Siyuan
    Qian, Yu
    Liu, Shuhui
    Hu, Wenhao
    Meng, Xun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (09) : 1013 - 1027
  • [35] A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine
    Le Joncour, Vadim
    Martins, Ana
    Puhka, Maija
    Isola, Jorma
    Salmikangas, Marko
    Laakkonen, Pirjo
    Joensuu, Heikki
    Barok, Mark
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1721 - 1730
  • [36] CKD-703, a novel antibody-drug conjugate targeting cMET with an enhanced therapeutic index in solid tumors
    Lee, Kwanwoo
    Kim, Sue-Youn
    Hong, Hye-Jin
    Park, Eunjeong
    Park, Jungok
    Hong, Seong-Ho
    Bae, Daekwon
    Ha, Nina
    Yeon, Sohn-Ji
    Hwang, Inchang
    Kim, Semi
    Lee, Yoonseok
    Lee, Ju-Hee
    CANCER RESEARCH, 2024, 84 (07)
  • [37] U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal Cancer
    Koganemaru, Shigehiro
    Kuboki, Yasutoshi
    Koga, Yoshikatsu
    Kojima, Takashi
    Yamauchi, Mayumi
    Maeda, Naoyuki
    Kagari, Takashi
    Hirotani, Kenji
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    Doi, Toshihiko
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (11) : 2043 - 2050
  • [38] Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs
    Andreev, Julian
    Thambi, Nithya
    Bay, Andres E. Perez
    Delfino, Frank
    Martin, Joel
    Kelly, Marcus P.
    Kirshner, Jessica R.
    Rafique, Ashique
    Kunz, Arthur
    Nittoli, Thomas
    MacDonald, Douglas
    Daly, Christopher
    Olson, William
    Thurston, Gavin
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 681 - 693
  • [39] Bystander activity and in vivo efficacy of a folate receptor α (FRα)-targeting antibody-drug conjugate with a novel peptide linker
    Qiu, Qifeng
    Wu, Rui
    Lanieri, Leanne
    Maloney, Erin
    Skaletskaya, Anna
    Jin, Shan
    Wang, Lintao
    Ab, Olga
    Ponte, Joe
    Setiady, Yulius
    Widdison, Wayne
    Keating, Thomas
    Chari, Ravi
    Gregory, Richard
    Hong, Erica
    CANCER RESEARCH, 2017, 77
  • [40] Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
    Petrul, Heike M.
    Schatz, Christoph A.
    Kopitz, Charlotte C.
    Adnane, Lila
    McCabe, Timothy J.
    Trail, Pamela
    Ha, Sha
    Chang, Yong S.
    Voznesensky, Andrei
    Ranges, Gerald
    Tamburini, Paul P.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 340 - 349
12345